Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2
Clinical trial NCT06316843 · COMPLETED
Trial details
- NCT number
- NCT06316843
- Sponsor
- Bateman Horne Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-15
- Primary completion
- 2024-10-31
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.